Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

PHASE4RecruitingINTERVENTIONAL

Enrollment

260

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Rheumatoid Arthritis (RA)Rituximab (RTx)

Interventions

DRUG

Rituximab 200mg/6months

perfusion of Rituximab 200mg

DRUG

Rituximab 1g/6months

perfusion of Rituximab 1g

Trial Locations (1)

RECRUITING

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER